The future of Opdivo in cancer treatment is promising, with ongoing research aimed at expanding its use to other cancer types and improving its efficacy. Studies are also investigating biomarkers that can predict which patients are most likely to benefit from Opdivo. The development of new combination therapies and personalized treatment approaches holds significant potential for enhancing patient outcomes.
